#ITI#Molecular characterization of pandemic H1N1 influenza viruses isolated from Turkeys and pathogenicity of a human pH1N1 isolate in Turkeys#FTI#
#IRE#Suspected human-to-animal transmission of the 2009 pandemic H1N1 (pH1N1) virus has been reported in several animal species, including pigs, dogs, cats, ferrets, and turkeys. In this study we describe the genetic characterization of pH1N1 viruses isolated from breeder turkeys that was associated with a progressive drop in egg production. Sequence analysis of all eight gene segments from three viruses isolated from this outbreak demonstrated homology with other human and swine pH1N1 isolates. The susceptibility of turkeys to a human pH1N1 isolate was further evaluated experimentally. The 50% turkey infectious dose (TID50) for the human isolate A/Mexico/InDRE/4487/2009 was determined by inoculating groups of 810-week-old turkeys with serial 10-fold dilutions of virus by oronasal and cloacal routes. We estimated the TID50 to be between 1 × 105 and 1 × 106 TCID50. The pathogenesis of pH1N1 in oronasally or cloacally inoculated juvenile turkeys was also examined. None of the turkeys exhibited clinical signs, and no significant difference in virus shedding or seroconversion was observed between the two inoculation groups. More than 50% of the turkeys in both oronasal and cloacal groups shed virus beginning at 2 days postinoculation (dpi). All birds that actively shed virus seroconverted by 14 dpi. Virus antigen was demonstrated by immunohistochemistry in the cecal tonsils and bursa of Fabricius in two of the birds that were infected by the cloacal route. Virus transmission to naive contact turkeys was at best doubtful. This report provides additional evidence that pH1N1 can cross the species barrier and cause disease outbreaks in domestic turkeys. However, it appears that the reproductive status of the host as well as environmental factors such as concurrent infections, stress, the presence or absence of litter, and stocking density may also contribute to efficient infection and transmission of this agent. © American Association of Avian Pathologists 2010.#FRE#
#IPC#pandemic H1N1; pathogenesis; transmission; turkeys#FPC#
#IRF#Babiuk S., Albrecht R., Berhane Y., Marszal P., Richt J.A., Garcia-Sastre A., Pasick J., Weingartl H., 1918 and 2009 H1N1 influenza viruses are not pathogenic in birds, J. Gen. Virol., 91, pp. 339-342, (2010); 
Brown I.H., The epidemiology and evolution of influenza viruses in pigs, Vet. Microbiol., 74, pp. 29-46, (2000); 
Fanning T.G., Taubenberger J.K., Phylogenetically important regions of the influenza A H1 hemagglutinin protein, Virus Res., 65, pp. 33-42, (1999); 
Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., De Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson Jr. P.D., Boxrud D., Sambol A.R., Abid S.H., St. George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J., Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans, Science, 325, pp. 197-201, (2009); 
Gibbs A.J., Armstrong J.S., Downie J.C., From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge?, Virol. J., 6, (2009); 
Hoffmann E., Stech J., Guan Y., Webster R.G., Perez D.R., Universal primer set for the full-length amplification of all influenza A viruses, Arch. Virol., 146, pp. 2275-2289, (2001); 
Hofshagen M., Gjerset B., Er C., Tarpai A., Brun E., Dannevig B., Bruheim T., Fostad I.G., Iversen B., Hungnes O., Lium B., Pandemic influenza A(H1N1) v: Human to pig transmission in Norway?, Euro. Surveill., 14, (2009); 
Howden K.J., Brockhoff E.J., Caya F.D., McLeod L.J., Lavoie M., Ing J.D., Bystrom J.M., Alexandersen S., Pasick J.M., Berhane Y., Morrison M.E., Keenliside J.M., Laurendeau S., Rohonczy E.B., An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm, Can. Vet. J., 50, pp. 1153-1161, (2009); 
Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., Muramoto Y., Tamura D., Sakai-Tagawa Y., Noda T., Sakabe S., Imai M., Hatta Y., Watanabe S., Li C., Yamada S., Fujii K., Murakami S., Imai H., Kakugawa S., Ito M., Takano R., Iwatsuki-Horimoto K., Shimojima M., Horimoto T., Goto H., Takahashi K., Makino A., Ishigaki H., Nakayama M., Okamatsu M., Takahashi K., Warshauer D., Shult P.A., Saito R., Suzuki H., Furuta Y., Yamashita M., Mitamura K., Nakano K., Nakamura M., Brockman-Schneider R., Mitamura H., Yamazaki M., Sugaya N., Suresh M., Ozawa M., Neumann G., Gern J., Kida H., Ogasawara K., Kawaoka Y., In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses, Nature, 460, pp. 1021-1025, (2009); 
Kobinger G.P., Meunier I., Patel A., Pillet S., Gren J., Stebner S., Leung A., Neufeld J.L., Kobasa D., Von Messling V., Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus, J. Infect. Dis., 201, pp. 1000-1006, (2010); 
Kyriakis C.S., Olsen C.W., Carman S., Brown I.H., Brookes S.M., Doorsselaere J.V., Reeth K.V., Serologic cross-reactivity with pandemic (H1N1) 2009 virus in pigs, Europe, Emerg. Infect. Dis., 16, pp. 96-99, (2010); 
Lange E., Kalthoff D., Blohm U., Teifke J.P., Breithaupt A., Maresch C., Starick E., Fereidouni S., Hoffmann B., Mettenleiter T.C., Beer M., Vahlenkamp T.W., Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs, J. Gen. Virol., 90, pp. 2119-2123, (2009); 
Lee M.-S., Chang P.-C., Shien J.-H., Cheng M.-C., Shieh H.K., Identification and subtyping of avian influenza viruses by reverse transcription-PCR, J. Virol. Methods, 97, pp. 13-22, (2001); 
Ludwig S., Haustein A., Kaleta F., Scholtissek C., Recent Influenza A (H1N1) Infections of pigs and turkeys in northern Europe, Virology, 202, pp. 281-286, (1994); 
Maines T.R., Jayaraman A., Belser J.A., Wadford D.A., Pappas C., Zeng H., Gustin K.M., Pearce M.B., Viswanathan K., Shriver Z.H., Raman R., Cox N.J., Sasisekharan R., Katz J.M., Tumpey T.M., Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice, Science, 325, pp. 484-487, (2009); 
Mathieu C., Moreno V., Retama P., Gonzalez A., Rivera A., Fuller J., Jara C., Lecocq C., Rojas M., Garcia A., Vasquez M., Agredo M., Gutierrez C., Escobar H., Fasce R., Mora J., Garcia J., Fernandez J., Ternicier C., Avalos P., Pandemic (H1N1) 2009 in breeding turkeys, Valparaiso, Chile. Emerg, Infect. Dis., 16, pp. 709-711, (2010); 
Maurer-Stroh S., Ma J., Lee R.T.C., Sirota F.L., Eisenhaber F., Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites, Biol. Direct, 4, (2009); 
McDougald L.R., Blackhead disease (Histomoniasis) in poultry: A critical review, Avian Dis., 49, pp. 462-476, (2005); 
Munster V.J., De Wit E., Van Den Brand J.M., Herfst S., Schrauwen E.J., Bestebroer T.M., Van De Vijver D., Boucher C.A., Koopmans M., Rimmelzwaan G.F., Kuiken T., Osterhaus A.D., Fouchier R.A., Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets, Science, 325, pp. 481-483, (2009); 
Pantin-Jackwood M., Wasilenko J.L., Spackman E., Suarez D.L., Swayne D.E., Susceptibility of turkeys to pandemic-H1N1 virus by reproductive tract insemination, Virol. J., 7, (2010); 
Pascua P.N., Song M.S., Lee J.H., Park K.J., Kwon H.I., Baek Y.H., Hong S.P., Rho J.B., Kim C.J., Poo H., Ryoo T.S., Sung M.H., Choi Y.K., Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection, PLoS ONE, 4, (2009); 
Pedersen J.C., Hemagglutination-inhibition test for avian influenza virus subtype identification and the detection and quantitation of serum antibodies to the avian influenza virus, Methods Mol. Biol., 436, pp. 53-66, (2008); 
Pillai S.P., Pantin-Jackwood M., Jadhao S.J., Suarez D.L., Wang L., Yassine H.M., Saif Y.M., Lee C.W., Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys, Vaccine, 27, pp. 819-824, (2009); 
Pillai S.P., Pantin-Jackwood M., Yassine H.M., Saif Y.M., Lee C.W., The susceptibility of turkeys to influenza viruses of different origins implies their importance as potential intermediate hosts, Avian Dis., 54, 1 SUPPL., pp. 522-526, (2010); 
Reed L.J., Muench H.A., Simple method of estimating fifty percent endpoints, Am. J. Hyg., 27, pp. 493-497, (1938); 
Robertson J.S., Nicolson C., Bootman J.S., Major D., Robertson E.W., Wood J.M., Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus, J. Gen. Virol., 72, pp. 2671-2677, (1991); 
Russell C., Hanna A., Barrass L., Matrosovich M., Nunez A., Brown I.H., Choudhury B., Banks J., Experimental infection of turkeys with pandemic (H1N1) 2009 influenza virus (A/H1N1/09v), J. Virol., 83, pp. 13046-13047, (2009); 
Spackman E., Ip H.S., Suarez D.L., Slemons R.D., Stallknecht D.E., Analytical validation of a real-time reverse transcription polymerase chain reaction test for Pan-American lineage H7 subtype avian influenza viruses, J. Vet. Diag. Invest., 20, pp. 612-616, (2008); 
Spackman E., Senne D.A., Meyers T.J., Bulaga L.L., Garber L.P., Perdue M.L., Lohman K., Daum L.T., Suarez D.L., Development of a real-time reverse transcriptase PCR for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes, J. Clin. Microbiol., 40, pp. 3256-3260, (2002); 
Suarez D.L., Woolcock P.R., Bermudez A.J., Senne D.A., Isolation from turkey breeder hens of a reassortant H1N2 influenza virus with swine, human, and avian lineage genes, Avian Dis., 46, pp. 111-121, (2002); 
Suzuki Y., Sialobiology of influenza: Molecular mechanism of host range variation of influenza viruses, Biol. Pharm. Bull., 28, pp. 399-408, (2005); 
Swayne D.E., Pantin-Jackwood M., Kapczynski D., Spackman E., Suarez D.L., Susceptibility of poultry to pandemic (H1N1) 2009 virus, Emerg. Infect. Dis., 15, pp. 2061-2063, (2009); 
Swayne D.E., Slemons R.D., Using mean infectious does of high-and low-pathogenicity avian influenza viruses originating from wild duck and poultry as one measure of infectivity and adaptation to poultry, Avian Dis., 52, pp. 455-460, (2008); 
Tang Y., Lee C.W., Zhange Y., Senne D.A., Dearth R., Byrum B., Perez D.R., Suarez D.L., Saif Y.M., Isolation and characterization of H3N2 influenza A virus from turkeys, Avian Dis., 49, pp. 207-213, (2005); 
Taubenberger J.K., Morens D.M., 1918 influenza: The mother of all pandemics, Emerg. Infect. Dis., 12, pp. 15-22, (2006); 
Terregino C., De Nardi R., Nisi R., Cilloni F., Salviato A., Fasolato M., Capua I., Resistance of turkeys to experimental infection with an early 2009 Italian human influenza A(H1N1)v virus isolate, Euro. Surveill., 14, (2009); 
Weingartl H.M., Berhane Y., Hisanaga T., Neufeld J., Kehler H., Emburry-Hyatt C., Hooper-Mcgreevy K., Kasloff S., Dalman B., Bystrom J., Alexandersen S., Li Y., Pasick J., Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd, J. Virol., 84, pp. 2245-2256, (2010); 
Yang M., Berhane Y., Salo T., Li M., Hole K., Clavijo A., Development and application of monoclonal antibodies against avian influenza virus nucleoprotein, J. Virol. Methods, 147, pp. 265-274, (2008); 
Yassine H.M., Al-Natour M.Q., Lee C.W., Saif Y.M., Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses, Virol. J., 4, (2007)#FRF#
